Prucasoft 2 Mg 14 Tablets

Prucasoft 2 Mg 14 Tablets

Description:

Prucasoft 2 mg 14 tablets is a prescription gastrointestinal medicine containing prucalopride, a selective high‑affinity 5‑HT4 receptor agonist used for the treatment of chronic constipation. It works by stimulating colonic motility and enhancing bowel movements, helping patients who suffer from infrequent or difficult defecation. Prucasoft is formulated as film‑coated tablets for oral use in adults under medical supervision to restore more regular bowel function and improve quality of life in chronic constipation.

Indications:

• Treatment of chronic constipation in adults when laxatives fail to provide adequate relief.
• Management of infrequent bowel movements associated with impaired colonic motility.
• Relief of symptoms related to chronic constipation such as hard stools, straining, and a feeling of incomplete evacuation.
• Improvement of bowel frequency and facilitation of regular defecation in patients with long‑standing constipation.

Active Ingredients / Key Components:

• Prucalopride – 2 mg per film‑coated tablet.
• Excipients (tablet core and film coat) – exact composition and concentrations , please check the product leaflet or the manufacturer’s official website. Refer to the package leaflet for full excipient list.

Dosage & Administration / How to Use:

• Usual adult dose: 2 mg (one tablet) once daily, or as directed by your physician.
• Swallow the tablet whole with a glass of water. Do not crush or chew the film‑coated tablet.
• Can be taken with or without food, preferably at the same time each day to maintain consistent effect.
• Use only under medical supervision, especially in elderly patients or those with other medical conditions.
• Patients with severe renal impairment or other organ dysfunction may require dose adjustment; follow your doctor’s instructions.
• Do not exceed the prescribed dose. If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose.
• Duration of treatment should be determined by your physician based on response and tolerability. Regular follow‑up is recommended to reassess the need for ongoing therapy.

Clinical Benefits:

• Stimulates colonic mass movements by activating 5‑HT4 receptors, providing the main propulsive force for defecation.
• Improves bowel movement frequency in adults with chronic constipation who do not respond adequately to conventional laxatives.
• Helps reduce constipation‑related symptoms such as straining, hard stools, and a sensation of incomplete bowel emptying.
• Targets impaired gastrointestinal motility, offering a more physiological approach compared with traditional laxatives.

Warnings & Contraindications:

• Contraindicated in patients with intestinal perforation or obstruction, severe inflammatory conditions of the intestinal tract (such as Crohn’s disease, ulcerative colitis, toxic megacolon/megarectum), or suspected bowel obstruction.
• Do not use if you are allergic or hypersensitive to prucalopride or any of the excipients in the formulation.
• Use with caution in patients with severe renal impairment, severe hepatic impairment, or a history of significant cardiovascular disease; dose adjustment or special monitoring may be required.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Prucalopride should be used in pregnancy or lactation only if clearly needed and prescribed by a physician.
• Consult your doctor before use if you have a history of arrhythmias, ischemic heart disease, heart failure, or other cardiac conditions.
• Not recommended for use in children and adolescents unless specifically prescribed by a specialist, as safety and efficacy data are limited.
• If you develop severe abdominal pain, persistent diarrhea, rectal bleeding, or symptoms of bowel obstruction, stop taking the medicine and seek medical attention immediately.
• Consult your doctor before use if you are taking other medications, especially those affecting gastrointestinal motility, cardiovascular drugs, or medicines that may alter electrolyte balance.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, abdominal pain, nausea, diarrhea, flatulence, and dizziness, especially during the first days of treatment.
• Some patients may experience fatigue, vomiting, or changes in appetite.
• Serious but less common side effects can include severe abdominal pain, signs of allergic reaction (rash, itching, swelling of the face or throat, difficulty breathing), or significant changes in heart rhythm. Seek immediate medical attention if these occur.
• If side effects are persistent, severe, or concerning, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Active ingredient: prucalopride 2 mg per film‑coated tablet.
• Form: film‑coated oral tablets.
• Pack size: 14 tablets per pack.
• Intended use: prescription medicine for chronic constipation in adults, used under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.